• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷公藤红素通过抑制 CXCR4 相关信号通路及体内抑制肿瘤生长对肝癌的潜在抗癌作用。

Potential Anticancer Effect of Celastrol on Hepatocellular Carcinoma by Suppressing CXCR4-related Signal and Impeding Tumor Growth in Vivo.

机构信息

Department of General Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan.

Department of General Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan.

出版信息

Arch Med Res. 2020 May;51(4):297-302. doi: 10.1016/j.arcmed.2020.03.001. Epub 2020 Mar 10.

DOI:10.1016/j.arcmed.2020.03.001
PMID:32169299
Abstract

BACKGROUND

Potential agents that can effectively treat hepatocellular carcinoma (HCC) are being continuously explored.

METHODS

Celastrol extracted from roots of an ancient Chinese herb, Tripterygium wilfordii (Thunder god vine), has been identified as a potential anti-tumor agent. In this study, the molecular mechanisms underlying the action of celastrol on cell proliferation and chemokine CXCR4-related signal pathway associated with tumor growth were investigated.

RESULTS

The CXCR4 expression was diminished by celastrol treatment in a dose-dependent manner, and its downstream associated pathways, including PI3K and Akt were also downregulated. Celastrol also significantly attenuated proliferation and migration ability of HCC cells, and induced cell apoptosis in vitro. Additionally, significant inhibition of HCC growth was observed in the celastrol-treated group as compared with the control group in vivo as well.

CONCLUSION

Celastrol is capable of attenuating cell proliferation and inducing apoptosis, leading to inhibition of HCC growth through the suppression of CXCR4-related signal pathway.

摘要

背景

目前正在不断探索能够有效治疗肝细胞癌(HCC)的潜在药物。

方法

从雷公藤的根部提取的雷公藤红素已被确定为一种潜在的抗肿瘤药物。本研究旨在探讨雷公藤红素对细胞增殖和与肿瘤生长相关的趋化因子 CXCR4 相关信号通路的作用机制。

结果

雷公藤红素处理呈剂量依赖性降低 CXCR4 的表达,其下游相关通路,包括 PI3K 和 Akt 也被下调。雷公藤红素还显著减弱 HCC 细胞的增殖和迁移能力,并在体外诱导细胞凋亡。此外,与对照组相比,雷公藤红素处理组在体内也显著抑制 HCC 的生长。

结论

雷公藤红素能够通过抑制 CXCR4 相关信号通路,减弱细胞增殖并诱导细胞凋亡,从而抑制 HCC 的生长。

相似文献

1
Potential Anticancer Effect of Celastrol on Hepatocellular Carcinoma by Suppressing CXCR4-related Signal and Impeding Tumor Growth in Vivo.雷公藤红素通过抑制 CXCR4 相关信号通路及体内抑制肿瘤生长对肝癌的潜在抗癌作用。
Arch Med Res. 2020 May;51(4):297-302. doi: 10.1016/j.arcmed.2020.03.001. Epub 2020 Mar 10.
2
Celastrol downregulates E2F1 to induce growth inhibitory effects in hepatocellular carcinoma HepG2 cells.雷公藤红素通过下调 E2F1 诱导肝癌 HepG2 细胞生长抑制作用。
Oncol Rep. 2017 Nov;38(5):2951-2958. doi: 10.3892/or.2017.5971. Epub 2017 Sep 19.
3
Integrating Network Pharmacology with in vitro Experiments to Validate the Efficacy of Celastrol Against Hepatocellular Carcinoma Through Ferroptosis.基于网络药理学与体外实验整合分析验证雷公藤红素通过铁死亡途径抗肝癌的作用机制
Drug Des Devel Ther. 2024 Jul 22;18:3121-3141. doi: 10.2147/DDDT.S450324. eCollection 2024.
4
Celastrol induces mitochondria-mediated apoptosis in hepatocellular carcinoma Bel-7402 cells.雷公藤红素诱导肝癌Bel-7402细胞发生线粒体介导的凋亡。
Am J Chin Med. 2015;43(1):137-48. doi: 10.1142/S0192415X15500093. Epub 2015 Feb 5.
5
Celastrol Enhances the Anti-Liver Cancer Activity of Sorafenib.雷公藤红素增强索拉非尼的抗肝癌活性。
Med Sci Monit. 2019 Jun 1;25:4068-4075. doi: 10.12659/MSM.914060.
6
Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo.雷公藤红素通过体外和体内调节 STAT3/JAK2 信号级联抑制人肝癌细胞的生长并诱导其凋亡。
Cancer Prev Res (Phila). 2012 Apr;5(4):631-43. doi: 10.1158/1940-6207.CAPR-11-0420. Epub 2012 Feb 27.
7
Celastrol suppresses nitric oxide synthases and the angiogenesis pathway in colorectal cancer.雷公藤红素抑制结直肠癌中的一氧化氮合酶和血管生成途径。
Free Radic Res. 2019 Mar;53(3):324-334. doi: 10.1080/10715762.2019.1575512. Epub 2019 Feb 18.
8
Celastrol enhanced the anticancer effect of lapatinib in human hepatocellular carcinoma cells in vitro.雷公藤红素在体外增强了拉帕替尼对人肝癌细胞的抗癌作用。
J BUON. 2014 Apr-Jun;19(2):412-8.
9
Celastrol inhibits the HIF-1α pathway by inhibition of mTOR/p70S6K/eIF4E and ERK1/2 phosphorylation in human hepatoma cells.雷公藤红素通过抑制人肝癌细胞中的mTOR/p70S6K/eIF4E和ERK1/2磷酸化来抑制HIF-1α通路。
Oncol Rep. 2014 Jul;32(1):235-42. doi: 10.3892/or.2014.3211. Epub 2014 May 23.
10
Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms.藜芦醇对二乙基亚硝胺诱导的大鼠肝癌的保护作用及其机制。
Eur J Pharmacol. 2016 Aug 5;784:173-80. doi: 10.1016/j.ejphar.2016.04.045. Epub 2016 May 12.

引用本文的文献

1
Chinese herbal medicines: the modifier of hepatocellular carcinoma targeting Wnt/β-catenin signaling pathway.中草药:靶向Wnt/β-连环蛋白信号通路的肝细胞癌调节剂
Front Pharmacol. 2025 Aug 25;16:1626251. doi: 10.3389/fphar.2025.1626251. eCollection 2025.
2
Recent Trends in anti-tumor mechanisms and molecular targets of celastrol.雷公藤红素的抗肿瘤作用机制及分子靶点的最新研究进展。
Int J Biol Sci. 2024 Oct 7;20(14):5510-5530. doi: 10.7150/ijbs.99592. eCollection 2024.
3
New perspectives on chemokines in hepatocellular carcinoma therapy: a critical pathway for natural products regulation of the tumor microenvironment.
探讨趋化因子在肝细胞癌治疗中的新视角:天然产物调控肿瘤微环境的关键途径。
Front Immunol. 2024 Aug 14;15:1456405. doi: 10.3389/fimmu.2024.1456405. eCollection 2024.
4
Celastrol induces ferroptosis by suppressing RRM2 in hepatocellular carcinoma.雷公藤红素通过抑制肝癌中的核糖核苷酸还原酶M2亚基诱导铁死亡。
Heliyon. 2024 Jul 2;10(13):e33936. doi: 10.1016/j.heliyon.2024.e33936. eCollection 2024 Jul 15.
5
The Promising Therapeutic Potential of Celastrol for Fibrotic Diseases: A Systematic Literature Review on Its Mechanism.雷公藤红素在纤维化疾病中的潜在治疗前景:关于其作用机制的系统文献综述
Cureus. 2023 Aug 28;15(8):e44269. doi: 10.7759/cureus.44269. eCollection 2023 Aug.
6
Celastrol attenuates human parvovirus B19 NS1‑induced NLRP3 inflammasome activation in macrophages.毛地黄皂苷抑制人细小病毒 B19 NS1 诱导的巨噬细胞中的 NLRP3 炎性体激活。
Mol Med Rep. 2023 Oct;28(4). doi: 10.3892/mmr.2023.13080. Epub 2023 Sep 1.
7
CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment.CXC 趋化因子受体 4(CXCR4)在癌症治疗中的阻断作用。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7945-7968. doi: 10.1007/s00432-022-04444-w. Epub 2023 Mar 11.
8
Celastrol: An Update on Its Hepatoprotective Properties and the Linked Molecular Mechanisms.雷公藤红素:其肝脏保护特性及相关分子机制的最新进展
Front Pharmacol. 2022 Apr 4;13:857956. doi: 10.3389/fphar.2022.857956. eCollection 2022.
9
Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma.中药及其活性成分在肝细胞癌治疗中的现状
J Hepatocell Carcinoma. 2022 Feb 9;9:41-56. doi: 10.2147/JHC.S346047. eCollection 2022.
10
CXCR4 promotes gefitinib resistance of Huh7 cells by activating the c-Met signaling pathway.CXCR4 通过激活 c-Met 信号通路促进 Huh7 细胞对吉非替尼的耐药性。
FEBS Open Bio. 2021 Nov;11(11):3115-3125. doi: 10.1002/2211-5463.13305. Epub 2021 Oct 19.